
Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
Fundamental Venture The board Apparatuses for Remote Groups - 2
7 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times - 3
A Republican elected governor in California? It's not as far-fetched as it sounds. - 4
Investigating Inside Plan and Home Style: Change Your Residing Space - 5
The most effective method to Go with Informed Choices on Vehicle Leases
Are your hormones imbalanced? Doctors explain how to know if you need testing
Reveal Less popular Authentic Realities You Didn't Learn in School
Roman around the Christmas tree | Space photo of the day for Dec. 25, 2025
2024 Ferrari Roma With Just One Owner & 3,300 Miles For Sale At $...
Tributes pour in for MIT professor Nuno Loureiro amid unresolved shooting case
Addressing sleep apnea early might decrease chances of developing Parkinson's disease
Zelensky names spy chief to head presidential office after corruption row
10 Demonstrated Tips to Expand Your New Android Cell phone: A Thorough Aide
Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps













